Lin et al. reported that FLOT1 was markedly up-regulated in human breast cancer cells and tissues, and knock-down of FLOT1 inhibited the proliferation and tumorigenesis of breast cancer cells through the Akt/FOXO3a pathway [21]. This evidence concerns the gene FOXO3 and breast cancer.